Kolexia
Clatot Florian
Oncologie médicale
Centre Henri-Becquerel
Rouen, France
193 Activités
155 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Carcinome épidermoïde Métastase tumorale Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Récidive tumorale locale Glioblastome Tumeurs du cerveau

Industries

MSD
21 collaboration(s)
Dernière en 2023
Merck-Serono
19 collaboration(s)
Dernière en 2023
Novartis
12 collaboration(s)
Dernière en 2023
AstraZeneca
11 collaboration(s)
Dernière en 2023

Dernières activités

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors: Phase 1/2 Dose Escalation and Cohort Expansion Study Evaluating MCLA-158 (Petosemtamab) as Single Agent or in Combination in Advanced Solid Tumors
Essai Clinique (Merus N.V.)   01 mars 2024
French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment.
Bulletin du cancer   27 février 2024
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
Translational oncology   09 février 2024
National standard for the treatment of squamous cell carcinoma of upper aerodigestive tract.
Bulletin du cancer   08 février 2024
Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy.
Cancer research communications   26 décembre 2023
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
JAMA   07 décembre 2023
Comité Tennis Seine Maritime - Facebook
Facebook   26 novembre 2023
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
BMC cancer   03 novembre 2023
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors.
Nature medicine   19 octobre 2023
PembroMetaRT: Randomized Trial of Loco-regional Radiotherapy Added to Pembrolizumab Alone or With Chemotherapy Versus Systemic Treatment Alone for Patients With Newly Diagnosed Head and Neck Squamous Cell Carcinoma With Synchronous Metastases
Essai Clinique (Unicancer)   12 octobre 2023